The analytical development department of Zinereo Pharma provides services for the development and validation of analytical methods according to the ICH guidelines in the following stages:
We provide services for the development and evaluation of dosage forms, which includes the following activities:
All the development studies are carried out in accordance with our GMP certification.
The manufacturing of pilot and industrial batches for registration purposes is conducted in our own facilities or third-party facilities always in accordance with the GMP system.
SHORT AND LONG-TERM PHYSICAL AND CHEMICAL STABILITY UNDER THE ICH GUIDELINES
We have ICH-approved climatic chambers (25ºC/60%RH; 30ºC/65%RH, 30ºC/75 and 40ºC/75%RH) guaranteeing that all the necessary humidity and temperature parameters are being monitored at all times. They all have an electronic system to record humidity and temperature values.
This makes it possible to conduct stability studies of dosage forms for the purpose of obtaining documentary evidence on how physical, physical-chemical, microbiological and biological characteristics vary over time under the influence of environmental factors such as humidity, light and temperature, as well to establish storage conditions and expiration dates.
We provide manufacturing services for third parties covered by our Authorization as Medicine Manufacturers and our GMP Certification.
The company is currently authorized to manufacture the following dosage forms:
We are specialized in supplying the Spanish market with all sorts of healthcare and pharmaceutical products.
Our storage and distribution facilities, which extend over 3,000 m² and whose controlled temperature ranges between 15-25ºC and 2-8ºC, have been authorized as a Distributor and have received the Good Distribution Practices Certification.
Our staff is highly capable of adapting to the demand of laboratories and clients.
We provide the following services:
A Relva, s/n, O Porriño, 36410 Pontevedra, SPAIN
(+34) 986 34 52 00 | hola@zinereopharma.com
© ZINEREO PHARMA, 2026